Key result
Routine postimplant defibrillator testing reveals a ~3% failure rate regardless of implant time or LVEF.
Why the study?
Does routine postimplant defibrillator testing identify device failures in patients with ICDs?
Observational (n=764)
Yes
Does routine postimplant defibrillator testing identify device failures in patients with ICDs?
Routine postimplant ICD testing identifies a 3.1% failure rate, suggesting the practice may be clinically justified to mitigate the risk of sudden cardiac death.
Answers are grounded in this paper and cite their sources.
May warrant selective postimplant testing in ICD recipients; leaves open whether routine use improves outcomes without randomized data.
To reassess the function of the implantable cardioverter defibrillator (ICD) many electrophysiology centers perform a second test after the initial test at implant. A prospective multicenter study evaluated the necessity and yield of routine postimplant defibrillator testing. The results of 843 postimplant defibrillator tests were collected from 31 centers. The 764 routine tests in which ventricular fibrillation was successfully induced were analyzed. Variables examined included patient age, presenting arrhythmia, underlying heart disease, left ventricular ejection fraction, defibrillator age, make and model of ICD, electrode system, defibrillation threshold, polarity, and waveform. The overall failure rate was 3.1% (24/764). Units tested later than 365 days after implant tended to have a higher failure rate than those tested within the first month or the next eleven months (6.5%, 3.0%, 2.3%, respectively, P = 0.374). The failure rate was higher in patients with left ventricular ejection fraction < 40% than those with higher ejection fractions (3.8% vs 2.0%, P = 0.167). These trends did not reach statistical significance. No other baseline characteristic was associated with higher failure rates. Routine testing of ICDs reveals an overall failure rate of 3.1%. While the rate was low, defibrillator failure places the patient at high risk for sudden cardiac death. As any failure in this population is associated with a high risk of sudden cardiac death, routine defibrillator testing may be justified.
No takes yet. Share an insight, caveat, or question.
Brodsky et al. (1999) conducted an observational in Implantable cardioverter defibrillator (ICD) (n=764). Routine postimplant defibrillator testing was evaluated on Defibrillator failure. Routine postimplant defibrillator testing revealed an overall failure rate of 3.1% (24/764), with no significant differences based on time since implant or left ventricular ejection fraction.
Synapse has enriched 10 related papers. Consider them for comparative context: